Recurrent pregnancy loss can be devastating and exert a major impact on women, their partners, and society more broadly, but ...

Liver failure encompasses a range of severe clinical syndromes resulting from the deterioration of liver function, triggered ...

Tumor tissue and ascites from patients with ovarian cancer contain high levels of cells with all the hallmarks of regulatory T cells. These cells migrate into the tumor microenvironment in a ...

Taiwan’s REGiMMUNE and Europe-based Kiji Therapeutics are merging to create a globally minded regulatory T-cell biotech that already has its eyes set on an IPO. REGiMMUNE’s lead therapy ...

Arun Swaminathan assumes new role as chief executive officer of Coya Therapeutics: Houston Tuesday, November 5, 2024, 11:00 ...

Quell Therapeutics Ltd (“Quell”), a world leader in developing engineered T-regulatory (Treg) cell therapies for ...

Alireza Faridar, M.D., a neurologist at Houston Methodist Hospital, looked at (PDF) the IL-2 component of the combination in an investigator-initiated trial. The study randomized 38 people with mild ...

Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regu ...